Insulin-like growth factor-I and complications of prematurity: a focus on bronchopulmonary dysplasia

Ettore Capoluongo1, Franco Ameglio, Cecilia Zuppi

  • 1Laboratory of Molecular Biology, Institute of Biochemistry and Clinical Biochemistry, Catholic University, Rome, Italy. ecapoluongo@rm.unicatt.it

Insights

Low serum insulin-like growth factor-I (IGF-I) is linked to serious complications in premature newborns. Local IGF-I levels, particularly in the lungs, show different regulation compared to serum levels.

Area of Science:

  • Neonatal Medicine
  • Endocrinology
  • Pediatric Critical Care

Background:

  • Premature newborns face risks of serious complications like bronchopulmonary dysplasia, retinopathy of prematurity, necrotizing enterocolitis, and brain damage.
  • Low serum insulin-like growth factor-I (IGF-I) levels have been associated with these adverse outcomes.
  • Local IGF-I concentrations, specifically in lung epithelial lining fluid, are elevated in bronchopulmonary dysplasia, suggesting differential regulation.

Purpose of the Study:

  • To review the association between serum IGF-I levels and the development of complications in premature infants.
  • To highlight the discrepancy between systemic and local IGF-I regulation.
  • To provide methodological guidance for IGF-I assays in this population.

Main Methods:

  • Literature review focusing on studies investigating serum and local IGF-I levels in premature newborns.
  • Analysis of existing data linking IGF-I concentrations to specific neonatal complications.
  • Discussion of the implications of differential IGF-I regulation.

Main Results:

  • Low serum IGF-I is a potential biomarker for increased risk of major neonatal morbidities.
  • Local IGF-I levels, such as in lung epithelial lining fluid, can be significantly higher than systemic levels, indicating compartmentalized regulation.
  • The relationship between systemic and local IGF-I requires further clarification.

Conclusions:

  • Serum IGF-I levels are associated with significant complications in premature infants.
  • IGF-I is regulated differently in systemic circulation versus local tissue compartments.
  • Further research is needed to understand the interplay between systemic and local IGF-I and its clinical implications for managing neonatal complications.

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...